Cargando…
接受造血干细胞移植的Ph(+)急性淋巴细胞白血病患者一线应用国产达沙替尼与伊马替尼的疗效比较
OBJECTIVE: To investigate the efficacy of first-line administration of generic dasatinib or first-generation TKI (imatinib) in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph(+) ALL) treated by hematopoietic stem cell transplantation (HSCT). METHODS: Clinical features...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342843/ https://www.ncbi.nlm.nih.gov/pubmed/30180468 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.08.010 |